1. Home
  2. STRO vs PANL Comparison

STRO vs PANL Comparison

Compare STRO & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • PANL
  • Stock Information
  • Founded
  • STRO 2003
  • PANL 1996
  • Country
  • STRO United States
  • PANL United States
  • Employees
  • STRO N/A
  • PANL N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • PANL Marine Transportation
  • Sector
  • STRO Health Care
  • PANL Consumer Discretionary
  • Exchange
  • STRO Nasdaq
  • PANL Nasdaq
  • Market Cap
  • STRO 292.6M
  • PANL 289.9M
  • IPO Year
  • STRO 2018
  • PANL N/A
  • Fundamental
  • Price
  • STRO $2.73
  • PANL $5.67
  • Analyst Decision
  • STRO Strong Buy
  • PANL Strong Buy
  • Analyst Count
  • STRO 7
  • PANL 1
  • Target Price
  • STRO $12.14
  • PANL N/A
  • AVG Volume (30 Days)
  • STRO 888.5K
  • PANL 196.3K
  • Earning Date
  • STRO 11-13-2024
  • PANL 11-12-2024
  • Dividend Yield
  • STRO N/A
  • PANL 7.27%
  • EPS Growth
  • STRO N/A
  • PANL N/A
  • EPS
  • STRO N/A
  • PANL 0.47
  • Revenue
  • STRO $160,955,000.00
  • PANL $521,238,386.00
  • Revenue This Year
  • STRO N/A
  • PANL $8.04
  • Revenue Next Year
  • STRO N/A
  • PANL $13.05
  • P/E Ratio
  • STRO N/A
  • PANL $11.64
  • Revenue Growth
  • STRO 230.90
  • PANL 5.23
  • 52 Week Low
  • STRO $2.45
  • PANL $5.46
  • 52 Week High
  • STRO $6.13
  • PANL $9.53
  • Technical
  • Relative Strength Index (RSI)
  • STRO 39.12
  • PANL 27.19
  • Support Level
  • STRO $2.55
  • PANL $5.77
  • Resistance Level
  • STRO $2.76
  • PANL $5.85
  • Average True Range (ATR)
  • STRO 0.27
  • PANL 0.20
  • MACD
  • STRO -0.05
  • PANL -0.07
  • Stochastic Oscillator
  • STRO 18.51
  • PANL 3.35

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.

Share on Social Networks: